Navigation Links
Ohio State researchers design a viral vector to treat a genetic form of blindness
Date:11/2/2011

COLUMBUS, Ohio Researchers at Ohio State University Medical Center and Nationwide Children's Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.

The vector is part of a clinical trial investigating the use of gene therapy to cure choroideremia, a disease that affects an estimated 100,000 people worldwide. The trial is being conducted by researchers at the University of Oxford in England.

The vector was designed by Dr. Matthew During, professor of molecular virology, immunology and medical genetics and of neuroscience and neurological surgery at Ohio State, in collaboration with Robert MacLaren, professor of ophthalmology at the University of Oxford, who also leads the trial.

Researcher Dr. K. Reed Clark, director of the Clinical Manufacturing Facility at the Center for Gene Therapy, Nationwide Children's Hospital, and his team produced the clinical-grade vector that is administered to patients in the trial.

During, who is also a visiting professor of translational neuroscience at Oxford, was in the operating room during the pioneering surgery. "I and my colleagues are excited about contributing to this significant medical breakthrough," During says. "We have worked for many years to engineer and optimize viruses to safely deliver genes to humans, and the eye is an ideal target in many ways. The clinical vector manufacturing facility at Nationwide Children's Hospital is outstanding, and Dr. Clark and his team deserve congratulations for providing a clinical vector that for the first time offers these patients the possibility of an effective therapy."

During and his colleagues designed the viral vector to infect the light-sensitive photoreceptor cells that line the back of the eye and make up the retina. Choroideremia causes a degeneration of these photosensitive retinal cells and progressive blindness
'/>"/>

Contact: Darrell E. Ward
darrell.ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. More radionuclide therapy is better for prostate cancer patients
2. Preterm birth rate shows three year improvement in most states
3. Michigan State University tackles health needs of an aging statewide population
4. New findings could lower risk of suicide in men with prostate cancer
5. Florida poll: Research important for state economy, jobs
6. Wayne State to develop a computer-delivered intervention for alcohol use during pregnancy
7. You are what you eat: Low fat diet with fish oil slowed growth of human prostate cancer cells
8. Wayne State University study of heroin users to examine links between stress, drug use
9. Henry Ford Hospital first in United States to offer MKTP surgery as treatment option for vitiligo
10. Researchers have found evidence for the existence of a hypnotic state
11. Mayo Clinic study: PSA test valuable in predicting biopsy need, low-risk prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... Reporter , , TUESDAY, May 22 (HealthDay News) -- ... procedure, which involves threading a camera through the ... But a new study has found that patients ... less time-consuming CT-based colon scan. Colonoscopy ... colon cancer screening. Computed tomography (CT) colonography -- ...
(Date:5/23/2012)... tiny, resilient metal wire designed to gather and compress ... severe heterogeneous emphysema, a subtype of the disease that ... to the results of a multicenter international trial conducted ... a lung volume reduction coil (LVRC), can be easily ... more invasive procedures used to improve the lung function ...
(Date:5/22/2012)... Research Inc., a leading independent drug-formulation development ... its existing hot-melt extrusion (HME) capacity with ... mixer/extruder. , The 18mm Leistritz twin-screw ... and 19mm Baker Perkins extruder units, enhancing ... capabilities. Many projects have been successfully advanced ...
(Date:5/22/2012)... University of Kentucky Markey Cancer Center has received more ... bone marrow disease often caused by chemotherapy or radiation ... Evans Foundation, along with a $1.25 million donor gift, ... Evans Foundation grant will fund five research labs over ... Cincinnati Children,s Hospital, and one at the University of ...
(Date:5/22/2012)... Doheny HealthDay Reporter , , TUESDAY, May 22 ... 2 diabetes with earlier development of precancerous colon lesions ... screenings at a younger age than others. "Based ... should get screenings earlier, possibly at age 40, rather ... clinical gastroenterology fellow at Washington University in St. Louis. ...
Breaking Medicine News(10 mins):Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Tiny implanted coil improves lung function in patients with severe emphysema 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 3Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 3Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 2Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 3
... more recent federal statistics saw uptick in teen pregnancies ... Teen pregnancy rates in the United States declined from ... while the number of pregnancies among unmarried women increased ... in a report -- "Estimated Pregnancy Rates by Outcome ...
... new Web resource,that allows users to learn, share, ... was launched today by the Agency for Healthcare ... Care Innovations Exchange -,is available at http://www.innovations.ahrq.gov ... the federal government,s,repository for successful health care innovations. ...
... profile has been identified in the blood of chronic ... and treat the disease, researchers say. , They used ... large numbers of proteins and found among 96 chronic ... , We can diagnose this disease with a ...
... Including First-Timers Faldo, Weekley, Snedeker, Howell III, Diaz and ... ... Brad Faxon and Billy,Andrade, PGA TOUR Professionals and co-hosts of the ... The 2008 CVS Caremark Charity Classic is set for June 22 - ...
... inhibited the development of precancerous growths in a two-step ... signaling pathways known to contribute to cancer growth and ... Anderson Cancer Center report today at the American Association ... by contrast, activated those pathways, said first author Tricia ...
... WASHINGTON, April 14 Hispanic doctors from,across the ... innovations,affecting Latinos and the findings of three "Health ... Minority Health (OMH) and,the National Hispanic Medical Association ... annual conference of the National,Hispanic Medical Association, a ...
Other Medicine News:Health News:Teen Pregnancies, Abortions Drop From 1990 to 2004: CDC 2Health News:Teen Pregnancies, Abortions Drop From 1990 to 2004: CDC 3Health News:AHRQ Web Resource Features 100 Examples of Health Care Innovations and Tools 2Health News:AHRQ Web Resource Features 100 Examples of Health Care Innovations and Tools 3Health News:Potential blood test for chronic sinusitis identified 2Health News:CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field 2Health News:CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field 3Health News:Calorie restriction limits Calorie restriction inhibits, obesity fuels development of epithelial can 2Health News:NHMA, Office of Minority Health Unveil Findings of Summits to Eliminate Health Disparities at Conference April 17-20 2
(Date:5/22/2012)... -- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ... and commercialization of products for central nervous system ... posters at the Society for Research on Biological ... The first poster entitled Pleiomorphic Expression ... provides insight into the challenges faced by individuals ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
(Date:5/22/2012)... 22, 2012  Avaxia Biologics, Inc., a ... that act locally within the gastrointestinal tract, ... U.S. Patent 8,182,818, entitled "Methods of Using ... the Digestive Tract." This patent ... anti-TNF antibodies to treat radiation induced damage ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation 2Spain 26apos 3Bs Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season 14297 1Spain 26apos 3Bs Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season 14297 2Spain 26apos 3Bs Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season 14297 3Prodigy Diabetes Care LLC Expands Global Reach to European Diabetes Patients 58540 1Prodigy Diabetes Care LLC Expands Global Reach to European Diabetes Patients 58540 2Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 58538 1Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 58538 2Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 58538 3
... is,accumulating that depression is a risk factor for ... Health Watch. A,recent study found that people ages ... serotonin reuptake inhibitors,(SSRIs) had double the rate of ... points to depression itself as a source,of endocrine ...
... WIRE)--May 30, 2007 - CELSION CORPORATION,(AMEX:CLN) today ... dose,escalation study, using ThermoDox(R), to treat non-resectable ... a Cooperative Research,and Development Agreement (CRADA) was ... the National Institutes of Health, under,the leadership ...
Other Medicine Technology:Antidepressant Use May Boost Fracture Risk, From Harvard Women's,Health Watch 2Celsion Completes Enrollment in Phase I Liver Cancer Study 2Celsion Completes Enrollment in Phase I Liver Cancer Study 3
Corning 7078 Calibrated"to deliver". multi-pack plugged capacity 5 mL...
... and O.R. staff work hard to protect ... intravasation. Manual methods are complicated, time-consuming, and ... II Fluid Management System for hysteroscopy, designed ... irrigation. It has been developed to provide ...
... precision 4mL PYREX volumetric pipets ... Contain" (TC - bottom line) ... top line) to specifications for ... are color-coded with colored graduations ...
1000L...
Medicine Products: